Sarah Reiter Net Worth

The estimated Net Worth of Sarah Reiter is at least $10.9 mil dollars as of 3 February 2020. Ms. Reiter owns over 700 units of Arcadia Biosciences Inc stock worth over $10,868 and over the last 7 years she sold RKDA stock worth over $0. In addition, she makes $0 as Chief Commercial Officer at Arcadia Biosciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Reiter RKDA stock SEC Form 4 insiders trading

Sarah has made over 4 trades of the Arcadia Biosciences Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently she bought 700 units of RKDA stock worth $1,204 on 3 February 2020.

The largest trade she's ever made was buying 1,200 units of Arcadia Biosciences Inc stock on 10 September 2019 worth over $7,776. On average, Sarah trades about 475 units every 18 days since 2018. As of 3 February 2020 she still owns at least 3,800 units of Arcadia Biosciences Inc stock.

You can see the complete history of Ms. Reiter stock trades at the bottom of the page.

Sarah Reiter biography

Sarah Reiter is Chief Commercial Officer of the Company. Reiter has more than 20 years of experience in the agriculture and food industries. Most recently, Reiter was US country head for STK Bio-ag Technologies, where she managed sales, distribution and business development functions. She previously served in senior positions with Bayer CropScience, Syngenta and AgraQuest. Reiter holds a bachelor's degree in English from the University of California, Davis and a master's certificate in business administration from the Villanova School of Business. She is a frequent speaker at international conferences on agriculture and sustainability topics.

What's Sarah Reiter's mailing address?

Sarah's mailing address filed with the SEC is Mount Ridge Road, Roseville, Ramsey County, Minnesota, 55113-5499, United States.

Insiders trading at Arcadia Biosciences Inc

Over the last 9 years, insiders at Arcadia Biosciences Inc have traded over $35,492 worth of Arcadia Biosciences Inc stock and bought 2,813,834 units worth $22,335,794 . The most active insiders traders include Terri Csperling Peter V Mor..., Darby E Shupp, eAlbert D. Bolles. On average, Arcadia Biosciences Inc executives and independent directors trade stock every 49 days with the average trade being worth of $147,899. The most recent stock trade was executed by Mark Kawakami on 1 August 2024, trading 700 units of RKDA stock currently worth $1,442.

What does Arcadia Biosciences Inc do?

arcadia biosciences (nasdaq: rkda) develops and markets high-value food ingredients and nutritional oils that help meet consumer demand for a healthier diet. arcadia’s goodwheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. the company’s portfolio of agricultural traits are being developed to enable farmers around the world to be more productive and minimize the impact of agriculture on the environment. for more information visit www.arcadiabio.com.

Complete history of Ms. Reiter stock trades at Arcadia Biosciences Inc e Calyxt Inc

Arcadia Biosciences Inc executives and stock owners

Arcadia Biosciences Inc executives and other stock owners filed with the SEC include:

• Pamela Haley,
  CFO & Corp. Sec.
• Laura Pitlik,
  Chief Marketing Officer
• Kevin J. Comcowich,
  Chairman & Interim CEO
• Amy Yoder,
  Director
• Gregory Waller,
  Director
• Lilian Shackleford Murray,
  Director
• Peter Gajdos,
  Director
• Albert Bolles,
  Director
• Jamie Bechtel,
  Director
• Sarah Reiter,
  Chief Commercial Officer
• Zhongjin Lu,
  Director - Product Development
• Kevin Hodges,
  Vice President - Commercial Operations
• Donald Emlay,
  Vice President - Regulatory Affairs and Compliance
• Tracy Baker,
  Vice President - Product Innovation
• Pamela Haley,
  Chief Financial Officer
• Matthew Plavan,
  Chief Executive Officer, Director
• Kevin Comcowich,
  Chairman of the Board
• Stanley E. Jacot Jr.,
  Pres, CEO & Director
• Stan Jacot,
  Pres & CEO
• Dr. Zhongjin Lu Ph.D.,
  Director of Product Devel.
• Brian Schaffer,
  Sr. VP of Sales
• Belinda Yao,
  VP of Operations
• George Frederick John Gosbee,
  Director
• Darby E Shupp,
  Director
• Rajiv Shah,
  Director
• Wendy S. Neal,
  VP, Chief Legal Officer
• James Richard Reis,
  Director
• Uday Garg,
  Director
• Matthew A. Ankrum,
  Director
• Steven F. Brandwein,
  VP Finance and Administration
• Roger Salameh,
  VP Business Development
• Mark Wong,
  Director
• Vic C. Knauf,
  Chief Scientific Officer
• Eric J. Rey,
  President and CEO
• Don Emlay,
  VP Regulatory and Compliance
• Agribusiness Co Investments...,
  
• Terri Csperling Peter V Mor...,
  
• Randall Shultz,
  Chief Technology Officer
• Chris Cuvelier,
  Chief Growth Officer
• Laura Pitlik,
  Chief Marketing Officer
• Stanley Jr Jacot,
  Chief Executive Officer
• Deborah D Carosella,
  
• Thomas J. Schaefer,
  Chief Executive Officer
• Mark Kawakami,
  Chief Financial Officer